Marcel Koenig

586 total citations
17 papers, 500 citations indexed

About

Marcel Koenig is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Organic Chemistry. According to data from OpenAlex, Marcel Koenig has authored 17 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 4 papers in Organic Chemistry. Recurrent topics in Marcel Koenig's work include Cancer Mechanisms and Therapy (5 papers), Melanoma and MAPK Pathways (5 papers) and Cell death mechanisms and regulation (3 papers). Marcel Koenig is often cited by papers focused on Cancer Mechanisms and Therapy (5 papers), Melanoma and MAPK Pathways (5 papers) and Cell death mechanisms and regulation (3 papers). Marcel Koenig collaborates with scholars based in United States and Denmark. Marcel Koenig's co-authors include Yuanjun He, Michael D. Cameron, Claudia Ruiz, Xiaohai Li, Alok Tomar, Congxin Liang, Neela Patel, David D. Schlaepfer, Isabelle Tanjoni and Ssang‐Taek Lim and has published in prestigious journals such as Bioorganic & Medicinal Chemistry, Drug Metabolism and Disposition and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Marcel Koenig

17 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Koenig United States 11 281 150 121 93 66 17 500
Kathleen M. Gillooly United States 14 263 0.9× 166 1.1× 145 1.2× 74 0.8× 28 0.4× 17 778
Darcy Bates United States 12 391 1.4× 185 1.2× 91 0.8× 66 0.7× 105 1.6× 17 704
Carol Torcellini United States 10 290 1.0× 103 0.7× 231 1.9× 219 2.4× 23 0.3× 13 801
Annie Olivier France 10 262 0.9× 153 1.0× 160 1.3× 24 0.3× 68 1.0× 12 492
GR Pettit United States 10 509 1.8× 206 1.4× 170 1.4× 29 0.3× 66 1.0× 10 861
Enrique Poradosu United States 10 308 1.1× 135 0.9× 86 0.7× 24 0.3× 28 0.4× 17 556
André Richters Germany 17 480 1.7× 144 1.0× 212 1.8× 32 0.3× 57 0.9× 24 776
Yahao Bu United States 12 323 1.1× 146 1.0× 65 0.5× 26 0.3× 83 1.3× 16 515
Thomas E. Rawson United States 8 601 2.1× 262 1.7× 168 1.4× 79 0.8× 73 1.1× 17 857

Countries citing papers authored by Marcel Koenig

Since Specialization
Citations

This map shows the geographic impact of Marcel Koenig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Koenig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Koenig more than expected).

Fields of papers citing papers by Marcel Koenig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Koenig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Koenig. The network helps show where Marcel Koenig may publish in the future.

Co-authorship network of co-authors of Marcel Koenig

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Koenig. A scholar is included among the top collaborators of Marcel Koenig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Koenig. Marcel Koenig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Doebelin, Christelle, Yuanjun He, Sean Campbell, et al.. (2019). Discovery and Optimization of a Series of Sulfonamide Inverse Agonists for the Retinoic Acid Receptor-Related Orphan Receptor-α. Medicinal Chemistry. 15(6). 676–684. 2 indexed citations
2.
Asteian, Alice, Anne‐Laure Blayo, Yuanjun He, et al.. (2015). Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists. ACS Medicinal Chemistry Letters. 6(9). 998–1003. 25 indexed citations
3.
Fruscia, Paolo Di, Yuanjun He, Marcel Koenig, et al.. (2014). The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1). Bioorganic & Medicinal Chemistry Letters. 24(16). 3974–3978. 8 indexed citations
4.
Richard, David J., Thomas D. Bannister, William E. Pierceall, et al.. (2013). Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker. Bioorganic & Medicinal Chemistry. 21(21). 6642–6649. 43 indexed citations
5.
He, Yuanjun, Derek R. Duckett, Wei‐Min Chen, et al.. (2013). Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(1). 161–164. 19 indexed citations
6.
Bannister, Thomas D., Marcel Koenig, Yuanjun He, et al.. (2013). ML311: A Small Molecule that Potently and Selectively Disrupts the Protein-Protein Interaction of Mcl-1 and Bim: A Probe for Studying Lymphoid Tumorigenesis. Europe PMC (PubMed Central). 6 indexed citations
7.
Feng, Yangbo, Jeremy W. Chambers, Sarah Iqbal, et al.. (2013). A Small Molecule Bidentate-Binding Dual Inhibitor Probe of the LRRK2 and JNK Kinases. ACS Chemical Biology. 8(8). 1747–1754. 17 indexed citations
8.
He, Yuanjun, Theodore M. Kamenecka, Youseung Shin, et al.. (2011). Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) Inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(6). 1719–1723. 22 indexed citations
9.
Song, Xinyi, Yuanjun He, Marcel Koenig, et al.. (2011). Synthesis and SAR of 2,4-diaminopyrimidines as potent c-jun N-terminal kinase inhibitors. MedChemComm. 3(2). 238–243. 6 indexed citations
10.
Madoux, Franck, Marcel Koenig, Erik A. Nelson, et al.. (2011). Modulators of STAT Transcription Factors for the Targeted Therapy of Cancer (STAT3 Inhibitors). 16 indexed citations
11.
Noël, Romain, Youseung Shin, Xinyi Song, et al.. (2010). Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(9). 2732–2735. 15 indexed citations
12.
Tanjoni, Isabelle, Colin Walsh, Sean Uryu, et al.. (2010). PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments. Cancer Biology & Therapy. 9(10). 764–777. 147 indexed citations
13.
Shin, Youseung, Wei‐Ming Chen, Jeff E. Habel, et al.. (2009). Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(12). 3344–3347. 24 indexed citations
14.
Li, Xiaohai, Yuanjun He, Claudia Ruiz, Marcel Koenig, & Michael D. Cameron. (2009). Characterization of Dasatinib and Its Structural Analogs as CYP3A4 Mechanism-Based Inactivators and the Proposed Bioactivation Pathways. Drug Metabolism and Disposition. 37(6). 1242–1250. 134 indexed citations
15.
Koenig, Marcel, Dominik Sturm, Alexandra Prowald, Olaf‐Georg Issinger, & Mathias Montenarh. (1997). Interaction of p53 with protein kinase CK2 during SV40 induced entrance of quiescent cells into the cell cycle. International Journal of Oncology. 10(2). 405–11. 1 indexed citations
16.
Goodman, Jay S., et al.. (1973). Recurrent Endocarditis Due to Streptococcus viridans in an “Edentulous” Man. Southern Medical Journal. 66(3). 352–352. 3 indexed citations
17.
Kaye, Donald, Marcel Koenig, & Edward W. Hook. (1961). THE ACTION OF CERTAIN ANTIBIOTICS AND ANTIBIOTIC COMBINATIONS AGAINST PROTEUS MIRABILIS WITH DEMONSTRATION OF IN VITRO SYNERGISM AND ANTAGONISM. The American Journal of the Medical Sciences. 242(3). 320–330. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen M. Gillooly Breakdown of academic impact, for papers by Darcy Bates Breakdown of academic impact, for papers by Carol Torcellini Breakdown of academic impact, for papers by Annie Olivier Breakdown of academic impact, for papers by GR Pettit Breakdown of academic impact, for papers by Enrique Poradosu Breakdown of academic impact, for papers by André Richters Breakdown of academic impact, for papers by Yahao Bu Breakdown of academic impact, for papers by Thomas E. Rawson
Rankless by CCL
2026